About Pharmaforce Reports Private Limited
Data last updated:
Pharmaforce Reports Private Limited is a foreign private limited company based in Pune, Maharashtra, India, a subsidiary of Pharmaforce Internation Inc. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 02 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2013FTC147209. Its GSTIN is 27AAHCP1488K1ZX (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Llena Vijay Samant and Tom Nordhoy.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at C/Oflexisales Groundfloor A – Wing Unitno.2 Businessmantripark Vimannagar, Pune, Maharashtra, India – 411014.
As per the financials filed for FY 2019, the company reported a revenue of ₹1.12 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹13.69 Lakh (net margin 12.2%) and EBITDA of ₹19.64 Lakh (EBITDA margin 17.5%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website india.pharmaforce.biz.
Company details
Contact details
Pharmaforce Reports Private Limited's registered office is in Pune, Maharashtra. Its website is india.pharmaforce.biz. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressC/Oflexisales Groundfloor A – Wing Unitno.2 Businessmantripark Vimannagar, Pune, Maharashtra, India – 411014
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Pharmaforce Reports Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pharmaforce Reports is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Pharmaforce Reports Private Limited, buy the company report.
Financials of Pharmaforce Reports Private Limited
FY 2019 filings availablePharmaforce Reports Private Limited reported revenue of ₹1.12 Cr (down 15% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over three years, including a 15% fall in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.12 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.5% | ||||
| Net Profit Margin | 12.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmaforce Reports Private Limited, buy the company report.
Board of directors of Pharmaforce Reports Private Limited
Pharmaforce Reports has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Llena Vijay Samant | Director | 02 May 2013 | 13 Years 5 Months | Current |
| Tom Nordhoy | Director | 02 May 2013 | 13 Years 5 Months | Current |
| Snehal Sahadev Patil | Additional Director | 26 Apr 2021 | 5 Years 5 Months | Current |
| Asit Sharma Also directs: Eastin Tech LLP, Mahatran Infra Holdings Private Limited | Director | 18 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Pharmaforce Reports Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmaforce Reports Private Limitedthis company | ₹1.12 Cr (FY 2019) | ₹13.69 Lakh | 12.2% | -15.0% | Pune, Maharashtra, India | |
| Clinsearch Healthcare Solutions Private Limited | ₹1.1 Cr (FY 2024) | -11.0% | Thane, Maharashtra, India | |||
| Padm Laboratories Private Limited | ₹1.09 Cr (FY 2024) | -63.0% | Bangalore, Karnataka, India | |||
| Arkus Research Private Limited | ₹1.07 Cr (FY 2025) | -33.0% | South Bopal, Gujarat, India |
To see the full peer comparison of Pharmaforce Reports Private Limited, buy the company report.
Auditor
Pharmaforce Reports Private Limited is audited by N P DAKE & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N P DAKE & ASSOCIATES | FY 2019 | 139585W |
Shareholding
The shareholding of Pharmaforce Reports Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Pharmaforce Reports Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pharmaforce Reports Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmaforce Reports Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pharmaforce Reports has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCP1488K1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pharmaforce Reports Private Limited, buy the company report.
Recent activity
Pharmaforce Reports Private Limited has 9 board changes on record since 2013: 4 appointments and 5 cessations. The latest: Snehal Sahadev Patil ceased to be Additional Director on 07 Jan 2022.
Frequently asked questions
Pharmaforce Reports is an active foreign private limited company based in Pune, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 02 May 2013 (13+ years old) and is registered under CIN U74900PN2013FTC147209.
Pharmaforce Reports has 4 current directors:
- Llena Vijay Samant - Director
- Tom Nordhoy - Director
- Snehal Sahadev Patil - Additional Director
- Asit Sharma - Director
The latest financial statements of Pharmaforce Reports on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharmaforce Reports is 27AAHCP1488K1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pharmaforce Reports is U74900PN2013FTC147209. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmaforce Reports was incorporated on 02 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Pharmaforce Reports by revenue are Clinsearch Healthcare Solutions Private Limited, Padm Laboratories Private Limited, Arkus Research Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (other professional, scientific and technical activities).
Snehal Sahadev Patil ceased to be Additional Director on 07 Jan 2022. Snehal Sahadev Patil was appointed as Additional Director on 26 Apr 2021. Ashrafi Sagar Adhau ceased to be Director on 20 Jan 2020. Pharmaforce Reports has 9 board changes on record in total.
Pharmaforce Reports can be reached through the website india.pharmaforce.biz. Its registered office is in Pune, Maharashtra, India.
The registered office of Pharmaforce Reports is at COflexisales Groundfloor A – Wing Unitno.2 Businessmantripark Vimannagar, Pune, Maharashtra, India – 411014.
Pharmaforce Reports operates in the pharma industry, in the pharma contract r and d segment.